Compounds, Compositions, Methods, and Uses for Treating Cancer and Immunological Disorders

Fri, 17 Apr 2026 03:27:33 +0000
Intellectual Property

The European Patent Office granted Patent EP3820533A2 to IL-2RX, Inc. covering novel compounds and compositions for treating cancer and immunological disorders. The patent application, filed by inventors Soares and Hurt, was published April 8, 2026 under IPC classifications A61K 47/64, A61K 47/65, A61P 35/00, and A61P 37/02. The patent is designated for all EU member states and extended territories.